Voyager Therapeutics, Inc.
VYGR · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$65 | $132 | -$46 | -$71 |
| Dep. & Amort. | $5 | $4 | $6 | $5 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $15 | $11 | $0 | $0 |
| Change in WC | $35 | -$67 | $20 | $3 |
| Other Non-Cash | -$5 | -$3 | $7 | $9 |
| Operating Cash Flow | -$15 | $78 | -$13 | -$54 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$4 | -$3 | -$2 | -$2 |
| Net Acquisitions | $0 | $138 | $0 | $0 |
| Inv. Purchases | -$466 | -$224 | -$55 | -$15 |
| Inv. Sales/Matur. | $374 | $86 | $50 | $83 |
| Other Inv. Act. | $0 | -$138 | $0 | $0 |
| Investing Cash Flow | -$95 | -$142 | -$7 | $66 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $113 | $31 | $1 | $1 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $1 | $3 | $0 | $0 |
| Financing Cash Flow | $114 | $34 | $1 | $1 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $4 | -$30 | -$18 | $13 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $70 | $100 | $117 | $104 |
| End Cash | $74 | $70 | $99 | $117 |
| Free Cash Flow | -$19 | $75 | -$15 | -$55 |